CBD Life Sciences（CBDL）株式概要CBDライフサイエンス社は、カンナビジオールベースのオーガニック製品の開発・販売を行っている。 詳細CBDL ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長0/6過去の実績0/6財務の健全性0/6配当金0/6リスク分析最新の財務報告は1年以上前のものである US市場と比較して、過去 3 か月間の株価の変動が非常に大きい過去1年間で株主の希薄化は大幅に進んだ 意味のある時価総額がありません ( $2M )すべてのリスクチェックを見るCBDL Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueUS$Current PriceUS$0.0003400.0% 割高 内在価値ディスカウントEst. Revenue$PastFuture-5m2m2016201920222025202620282031Revenue US$178.4kEarnings US$26.1kAdvancedSet Fair ValueView all narrativesCBD Life Sciences Inc. 競合他社Hepion PharmaceuticalsSymbol: OTCPK:HEPAMarket cap: US$2.7mAdial PharmaceuticalsSymbol: NasdaqCM:ADILMarket cap: US$3.3mSciSparcSymbol: NasdaqCM:SPRCMarket cap: US$2.4mInMed PharmaceuticalsSymbol: NasdaqCM:INMMarket cap: US$7.7m価格と性能株価の高値、安値、推移の概要CBD Life Sciences過去の株価現在の株価US$0.000352週高値US$0.00152週安値US$0.0001ベータ01ヶ月の変化0%3ヶ月変化50.00%1年変化0%3年間の変化0%5年間の変化-99.86%IPOからの変化-99.90%最新ニュースお知らせ • May 16CBD Life Sciences Inc. has filed a Follow-on Equity Offering in the amount of $0.448 million.CBD Life Sciences Inc. has filed a Follow-on Equity Offering in the amount of $0.448 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 4,000,000,000 Price\Range: $0.000112 Discount Per Security: $0お知らせ • Jan 07CBD Life Sciences, Inc. Secures Breakthrough Walmart Marketplace Approval for Mushroom Supplement, Setting the Stage for Unprecedented GrowthCBD Life Sciences Inc. announce that its Mushroom Madness Rise Gummies, featuring a powerful Lion's Mane mushroom blend, have officially been approved for sale and are now available on Walmart Marketplace. This monumental approval opens the door for CBDL to tap into Walmart's expansive e-commerce ecosystem, providing a pathway to substantial revenue growth while strengthening its position in the rapidly expanding functional mushroom market. The global functional mushroom market continues to surge, projected to reach $42.4 billion by 2028, with Lion's Mane products leading the charge due to their cognitive health benefits. CBDL's Mushroom Madness Rise Gummies, formulated for focus, clarity, and enhanced mental performance, are well-positioned to meet the increasing demand for natural wellness solutions. Walmart Marketplace, recognized as one of the fastest-growing online retail platforms, boasts over 100 million monthly visitors. With third-party sellers generating substantial portions of Walmart's e-commerce revenue, the platform offers unmatched scalability and visibility for emerging brands. CBDL's entry onto Walmart Marketplace provides logistical efficiencies, enhanced consumer trust, and a direct line to an enormous, ever-expanding customer base. Industry reports indicate that third-party sellers often experience double-digit sales growth within months of launching on Walmart Marketplace. This offers CBDL an unprecedented opportunity to scale its revenues rapidly, further bolstered by Walmart's robust digital marketing support and fulfillment network. CBD Life Sciences has already achieved impressive financial growth, recording a 1405.46% increase in revenue since February 2024. The company expects Walmart Marketplace to significantly enhance its revenue stream, given the rapid consumer adoption of functional mushroom products and CBD-infused supplements. The Mushroom Madness Rise Gummies are a strategic addition to CBDL's product lineup, aligning with the company's commitment to offering scientifically formulated, high-efficacy wellness products. These gummies not only serve a growing wellness market but also position CBDL to capture a significant share of the $20 billion U.S. supplement industry. As part of its long-term strategy, CBDL plans to launch additional top-selling products on Walmart Marketplace, including its highly anticipated nano-CBD supplements and mushroom-enhanced nutritional powders.お知らせ • Dec 03CBD Life Sciences Inc. Announces New Delta-8 100MG Gummies Designed to Support Individuals Living with Alzheimer'sCBD Life Sciences Inc. announced the launch of its groundbreaking Delta-8 100mg Gummies, specially formulated to support individuals living with Alzheimer's disease. These expertly crafted gummies offer gentle relief and enhanced well-being, addressing the unique needs of patients and their families navigating the challenges of neurodegenerative conditions. CBD Life Sciences' entry into this specialized segment of the $6 billion U.S. edibles market positions the company as a pioneer in creating products tailored to an underserved demographic. As the population ages and awareness of natural alternatives grows, Delta-8 products are rapidly gaining traction as effective solutions for managing symptoms associated with Alzheimer's and related conditions. A Product Born from Real Needs and Scientific Innovation: The development of these gummies is deeply rooted in the stories of CBD Life Sciences' clients, who shared how Delta-8 products have positively impacted their loved ones living with Alzheimer's. This heartfelt feedback spurred the creation of a product aimed at addressing symptoms such as anxiety, restlessness, agitation, and mood swings, all while promoting cognitive calmness and overall quality of life.Delta-8, a naturally occurring cannabinoid, is celebrated for its mild yet effective benefits. Unlike more aggressive treatments, Delta-8 provides a balance of support without overwhelming psychoactive effects, making it an ideal choice for seniors seeking natural relief. Revenue and Growth Potential: The Alzheimer's population in the United States is expected to exceed 12.7 million by 2050, creating a significant and growing demand for targeted wellness products. Early projections indicate that this product line could contribute an additional $3 million in revenue within its first year, as CBD Life Sciences continues to meet the rising interest in cannabinoid-based solutions for elderly care. The senior segment of the edibles market is rapidly emerging as a key growth area. A recent study reported a 300% increase in cannabinoid use among individuals aged 65 and older over the past decade. This demographic is increasingly turning to natural products like Delta-8 for their ability to support physical and cognitive health without the side effects often associated with pharmaceuticals. Meeting the Needs of an Underserved Market: CBD Life Sciences'Delta-8 Gummies are designed with seniors in mind. These gummies are made from all-natural ingredients, offering easy consumption, precise dosing, and a discreet form factor. Rigorous third-party testing ensures their purity, potency, and consistency, providing families and caregivers with confidence in their safety and efficacy. The gummies' formulation emphasizes cognitive support and emotional balance, helping to manage the everyday challenges of Alzheimer's while offering peace of mind to those providing care. CBD Life Sciences: Setting the Standard in Innovation: The launch of the Delta-8 Gummies for Alzheimer's marks another milestone in CBD Life Sciences' remarkable growth trajectory. Since February 2024, the company has achieved a 1405.46% increase in revenue, driven by its commitment to delivering high-quality, innovative products that resonate with consumers. This latest product also highlights the company's strategic focus on expanding its reach in the health and wellness sector, where demand for cannabinoid-based solutions continues to skyrocket. By addressing the specific needs of aging individuals and their families, CBD Life Sciences solidifies its position as a trusted leader in the industry.お知らせ • Nov 02CBD Life Sciences Inc. Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into A Booming $20 Billion MarketCBD Life Sciences Inc. sets a new industry standard with its launch of a high-performance line of mushroom-infused gummies, designed to meet the surging demand for wellness products in a projected $20 billion market. Focused on energy, sleep, and sexual wellness, these unique formulations offer CBDL shareholders and new investors an unprecedented growth opportunity in an exploration sector. With an expanding consumer focus on holistic health and functional ingredients, CBDL's Rise, Dream, and Bloom Gummies each bring targeted benefits, including cognitive enhancement, restful sleep, and boosted vitality. These products are strategically positioned to address top wellness priorities, blending potent natural ingredients with advanced formulation technology. This launch is expected to significantly contribute to CBDL's revenue stream, enhancing shareholder value and setting the company apart as an innovator in functional wellness. Rise Gummies are formulated to support focus and energy, each containing 500mg of Lion's Mane Mushroom, 1 microgram of B12, and 25mg of Ginseng. This combination aligns with a growing segment of consumers seeking natural solutions to boost mental clarity and productivity. Dream Gummies provide natural support for relaxation and sleep, with 500mg of Reishi Mushroom, 25mg of Kava, and 10mg of 5-HTP. With sleep wellness now a top priority for many, Dream Gummies offer a non-habit-forming solution to support stress relief and emotional balance. Bloom Gummies offer a targeted formula for sexual wellness and vitality, incorporating 500mg of Cordyceps Mushroom along with Tongkat Ali, Ginkgo Biloba, Ginseng, L-Arginine, Ashwagandha, and Maca. With its pioneering approach to wellness, CBDL is dedicated to securing sustained value for investors by remaining at the forefront of natural health innovation.お知らせ • Oct 03CBD Life Sciences, Inc. Launches CBD Horse PasteCBD Life Sciences Inc. announced the launch of its latest product, the CBD Horse Paste. This veterinarian-designed formulation is the first of its kind, offering unparalleled support for horses facing both physical and psychological challenges. Equine health concerns such as muscle stiffness, joint pain, and anxiety can significantly affect a horse's well-being. The CBD Horse Paste addresses these issues with a unique combination of cannabinoids and terpenes, providing an easy-to-administer solution that stays in the horse's mouth longer than CBD oils, ensuring maximum absorption. Each syringe delivers 500mg of premium CBD with a flavor horses love, making it ideal for stress-inducing situations like farrier visits or long trailer rides. Key Benefits of CBD Horse Paste: Veterinarian-Designed Formulation: Created by equine health experts for maximum effectiveness. Comprehensive Health Support: Eases muscle stiffness, joint issues, and stress-related behaviors like boredom and anxiety. Easy-to-Use: Each syringe contains four doses, making it convenient for horse owners. Delicious Flavor: The paste's flavor ensures horses readily accept it. Versatile Application: Perfect for use during stressful situations, such as travel, farrier visits, and training sessions. Innovative CBD for Equine Wellness: The CBD Horse Paste not only addresses common equine health concerns but also serves as a natural alternative to traditional calming agents and medications. By leveraging the powerful properties of CBD and terpenes, horses can experience relief from arthritis-induced stiffness and joint pain, as well as a reduction in anxiety caused by environmental changes, isolation, or past trauma.お知らせ • Sep 24CBD Life Sciences, Inc. Announces Expanding Revenue Stream with Walmart MarketplaceCBD Life Sciences Inc. announced the launch of its product line on Walmart Marketplace. This milestone marks a significant leap in retail strategy, poised to drive substantial revenue growth and expand market reach to millions of potential customers. Market Expansion: By entering the Walmart Marketplace, the company are now accessible to one of the largest retail platforms in the world, boasting over 120 million monthly visitors. This launch strategically positions CBDL to significantly increase brand visibility and consumer base. Revenue Growth: Early forecasts project a substantial revenue boost, with a projected increase of 35% in annual sales due to this new distribution channel. The company revenue growth over the past 12 months has already seen a 20% rise, and the company expects accelerated growth driven by this expansion. Product Line on Walmart: The initial offerings will include top-selling Nano CBD Coffee Creamer, Mellow Mornings, and CBD Pain Cream, which have seen growing demand in local markets. These products, praised for their effectiveness, will now have national distribution, broadening customer base across the U.S. Investor Impact: This move opens additional streams of revenue that will enhance shareholder value. By diversifying sales channels, the company aim to increase its gross margins by 10% while driving stronger returns for investors over the next fiscal year. A Proven Path to Growth: As a small but rapidly growing company, the company recognize that entering high-traffic marketplaces like Walmart is a powerful catalyst for scaling. The company continue to prioritize innovation in product lines and have seen positive feedback from both consumers and local retailers. With products now on Walmart Marketplace, the company anticipates a robust competitive edge and a much larger footprint in the booming CBD sector, which is projected to reach $47.22 billion by 2028.最新情報をもっと見るRecent updatesお知らせ • May 16CBD Life Sciences Inc. has filed a Follow-on Equity Offering in the amount of $0.448 million.CBD Life Sciences Inc. has filed a Follow-on Equity Offering in the amount of $0.448 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 4,000,000,000 Price\Range: $0.000112 Discount Per Security: $0お知らせ • Jan 07CBD Life Sciences, Inc. Secures Breakthrough Walmart Marketplace Approval for Mushroom Supplement, Setting the Stage for Unprecedented GrowthCBD Life Sciences Inc. announce that its Mushroom Madness Rise Gummies, featuring a powerful Lion's Mane mushroom blend, have officially been approved for sale and are now available on Walmart Marketplace. This monumental approval opens the door for CBDL to tap into Walmart's expansive e-commerce ecosystem, providing a pathway to substantial revenue growth while strengthening its position in the rapidly expanding functional mushroom market. The global functional mushroom market continues to surge, projected to reach $42.4 billion by 2028, with Lion's Mane products leading the charge due to their cognitive health benefits. CBDL's Mushroom Madness Rise Gummies, formulated for focus, clarity, and enhanced mental performance, are well-positioned to meet the increasing demand for natural wellness solutions. Walmart Marketplace, recognized as one of the fastest-growing online retail platforms, boasts over 100 million monthly visitors. With third-party sellers generating substantial portions of Walmart's e-commerce revenue, the platform offers unmatched scalability and visibility for emerging brands. CBDL's entry onto Walmart Marketplace provides logistical efficiencies, enhanced consumer trust, and a direct line to an enormous, ever-expanding customer base. Industry reports indicate that third-party sellers often experience double-digit sales growth within months of launching on Walmart Marketplace. This offers CBDL an unprecedented opportunity to scale its revenues rapidly, further bolstered by Walmart's robust digital marketing support and fulfillment network. CBD Life Sciences has already achieved impressive financial growth, recording a 1405.46% increase in revenue since February 2024. The company expects Walmart Marketplace to significantly enhance its revenue stream, given the rapid consumer adoption of functional mushroom products and CBD-infused supplements. The Mushroom Madness Rise Gummies are a strategic addition to CBDL's product lineup, aligning with the company's commitment to offering scientifically formulated, high-efficacy wellness products. These gummies not only serve a growing wellness market but also position CBDL to capture a significant share of the $20 billion U.S. supplement industry. As part of its long-term strategy, CBDL plans to launch additional top-selling products on Walmart Marketplace, including its highly anticipated nano-CBD supplements and mushroom-enhanced nutritional powders.お知らせ • Dec 03CBD Life Sciences Inc. Announces New Delta-8 100MG Gummies Designed to Support Individuals Living with Alzheimer'sCBD Life Sciences Inc. announced the launch of its groundbreaking Delta-8 100mg Gummies, specially formulated to support individuals living with Alzheimer's disease. These expertly crafted gummies offer gentle relief and enhanced well-being, addressing the unique needs of patients and their families navigating the challenges of neurodegenerative conditions. CBD Life Sciences' entry into this specialized segment of the $6 billion U.S. edibles market positions the company as a pioneer in creating products tailored to an underserved demographic. As the population ages and awareness of natural alternatives grows, Delta-8 products are rapidly gaining traction as effective solutions for managing symptoms associated with Alzheimer's and related conditions. A Product Born from Real Needs and Scientific Innovation: The development of these gummies is deeply rooted in the stories of CBD Life Sciences' clients, who shared how Delta-8 products have positively impacted their loved ones living with Alzheimer's. This heartfelt feedback spurred the creation of a product aimed at addressing symptoms such as anxiety, restlessness, agitation, and mood swings, all while promoting cognitive calmness and overall quality of life.Delta-8, a naturally occurring cannabinoid, is celebrated for its mild yet effective benefits. Unlike more aggressive treatments, Delta-8 provides a balance of support without overwhelming psychoactive effects, making it an ideal choice for seniors seeking natural relief. Revenue and Growth Potential: The Alzheimer's population in the United States is expected to exceed 12.7 million by 2050, creating a significant and growing demand for targeted wellness products. Early projections indicate that this product line could contribute an additional $3 million in revenue within its first year, as CBD Life Sciences continues to meet the rising interest in cannabinoid-based solutions for elderly care. The senior segment of the edibles market is rapidly emerging as a key growth area. A recent study reported a 300% increase in cannabinoid use among individuals aged 65 and older over the past decade. This demographic is increasingly turning to natural products like Delta-8 for their ability to support physical and cognitive health without the side effects often associated with pharmaceuticals. Meeting the Needs of an Underserved Market: CBD Life Sciences'Delta-8 Gummies are designed with seniors in mind. These gummies are made from all-natural ingredients, offering easy consumption, precise dosing, and a discreet form factor. Rigorous third-party testing ensures their purity, potency, and consistency, providing families and caregivers with confidence in their safety and efficacy. The gummies' formulation emphasizes cognitive support and emotional balance, helping to manage the everyday challenges of Alzheimer's while offering peace of mind to those providing care. CBD Life Sciences: Setting the Standard in Innovation: The launch of the Delta-8 Gummies for Alzheimer's marks another milestone in CBD Life Sciences' remarkable growth trajectory. Since February 2024, the company has achieved a 1405.46% increase in revenue, driven by its commitment to delivering high-quality, innovative products that resonate with consumers. This latest product also highlights the company's strategic focus on expanding its reach in the health and wellness sector, where demand for cannabinoid-based solutions continues to skyrocket. By addressing the specific needs of aging individuals and their families, CBD Life Sciences solidifies its position as a trusted leader in the industry.お知らせ • Nov 02CBD Life Sciences Inc. Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into A Booming $20 Billion MarketCBD Life Sciences Inc. sets a new industry standard with its launch of a high-performance line of mushroom-infused gummies, designed to meet the surging demand for wellness products in a projected $20 billion market. Focused on energy, sleep, and sexual wellness, these unique formulations offer CBDL shareholders and new investors an unprecedented growth opportunity in an exploration sector. With an expanding consumer focus on holistic health and functional ingredients, CBDL's Rise, Dream, and Bloom Gummies each bring targeted benefits, including cognitive enhancement, restful sleep, and boosted vitality. These products are strategically positioned to address top wellness priorities, blending potent natural ingredients with advanced formulation technology. This launch is expected to significantly contribute to CBDL's revenue stream, enhancing shareholder value and setting the company apart as an innovator in functional wellness. Rise Gummies are formulated to support focus and energy, each containing 500mg of Lion's Mane Mushroom, 1 microgram of B12, and 25mg of Ginseng. This combination aligns with a growing segment of consumers seeking natural solutions to boost mental clarity and productivity. Dream Gummies provide natural support for relaxation and sleep, with 500mg of Reishi Mushroom, 25mg of Kava, and 10mg of 5-HTP. With sleep wellness now a top priority for many, Dream Gummies offer a non-habit-forming solution to support stress relief and emotional balance. Bloom Gummies offer a targeted formula for sexual wellness and vitality, incorporating 500mg of Cordyceps Mushroom along with Tongkat Ali, Ginkgo Biloba, Ginseng, L-Arginine, Ashwagandha, and Maca. With its pioneering approach to wellness, CBDL is dedicated to securing sustained value for investors by remaining at the forefront of natural health innovation.お知らせ • Oct 03CBD Life Sciences, Inc. Launches CBD Horse PasteCBD Life Sciences Inc. announced the launch of its latest product, the CBD Horse Paste. This veterinarian-designed formulation is the first of its kind, offering unparalleled support for horses facing both physical and psychological challenges. Equine health concerns such as muscle stiffness, joint pain, and anxiety can significantly affect a horse's well-being. The CBD Horse Paste addresses these issues with a unique combination of cannabinoids and terpenes, providing an easy-to-administer solution that stays in the horse's mouth longer than CBD oils, ensuring maximum absorption. Each syringe delivers 500mg of premium CBD with a flavor horses love, making it ideal for stress-inducing situations like farrier visits or long trailer rides. Key Benefits of CBD Horse Paste: Veterinarian-Designed Formulation: Created by equine health experts for maximum effectiveness. Comprehensive Health Support: Eases muscle stiffness, joint issues, and stress-related behaviors like boredom and anxiety. Easy-to-Use: Each syringe contains four doses, making it convenient for horse owners. Delicious Flavor: The paste's flavor ensures horses readily accept it. Versatile Application: Perfect for use during stressful situations, such as travel, farrier visits, and training sessions. Innovative CBD for Equine Wellness: The CBD Horse Paste not only addresses common equine health concerns but also serves as a natural alternative to traditional calming agents and medications. By leveraging the powerful properties of CBD and terpenes, horses can experience relief from arthritis-induced stiffness and joint pain, as well as a reduction in anxiety caused by environmental changes, isolation, or past trauma.お知らせ • Sep 24CBD Life Sciences, Inc. Announces Expanding Revenue Stream with Walmart MarketplaceCBD Life Sciences Inc. announced the launch of its product line on Walmart Marketplace. This milestone marks a significant leap in retail strategy, poised to drive substantial revenue growth and expand market reach to millions of potential customers. Market Expansion: By entering the Walmart Marketplace, the company are now accessible to one of the largest retail platforms in the world, boasting over 120 million monthly visitors. This launch strategically positions CBDL to significantly increase brand visibility and consumer base. Revenue Growth: Early forecasts project a substantial revenue boost, with a projected increase of 35% in annual sales due to this new distribution channel. The company revenue growth over the past 12 months has already seen a 20% rise, and the company expects accelerated growth driven by this expansion. Product Line on Walmart: The initial offerings will include top-selling Nano CBD Coffee Creamer, Mellow Mornings, and CBD Pain Cream, which have seen growing demand in local markets. These products, praised for their effectiveness, will now have national distribution, broadening customer base across the U.S. Investor Impact: This move opens additional streams of revenue that will enhance shareholder value. By diversifying sales channels, the company aim to increase its gross margins by 10% while driving stronger returns for investors over the next fiscal year. A Proven Path to Growth: As a small but rapidly growing company, the company recognize that entering high-traffic marketplaces like Walmart is a powerful catalyst for scaling. The company continue to prioritize innovation in product lines and have seen positive feedback from both consumers and local retailers. With products now on Walmart Marketplace, the company anticipates a robust competitive edge and a much larger footprint in the booming CBD sector, which is projected to reach $47.22 billion by 2028.お知らせ • Sep 18CBD Life Sciences, Inc. Unveils Groundbreaking Nutritional Supplement Infused with Mushroom Extracts, Set to Drive Revenue and Revolutionize WellnessCBD Life Sciences Inc. launched a cutting-edge nutritional supplement powder designed to harness the powerful health benefits of natural ingredients. This new supplement contains a proprietary blend of reishi mushroom extract, lion's mane mushroom extract, and ashwagandha root extract, offering an integrated approach to wellness by reducing stress, supporting brain health, and enhancing the immune system. Recent studies highlight the effectiveness of reishi extract, not only in boosting the immune system but also in slowing or stopping tumor growth, a feature that positions this product as an essential addition to the wellness market. The blend of lion's mane extract and ashwagandha root provides additional cognitive support and anti-inflammatory benefits, making it an all-around solution for physical and mental well-being. Unrivaled Benefits of Key Ingredients: Reishi Mushroom Extract: Renowned for its immune-boosting and anti-cancer properties, research suggests it can slow tumor growth, making it one of the most potent natural supplements available today. Lion's Mane Mushroom Extract: Known for supporting brain health, lion's mane helps to enhance cognitive function and promote nerve regeneration, ideal for those seeking long-term mental clarity. Ashwagandha Root Extract: Widely celebrated for reducing stress and its anti-inflammatory effects, ashwagandha contributes to overall mental health and physical recovery. Revenue Projections & Market Potential.With the global supplement market experiencing rapid growth, the introduction of this new product is projected to significantly boost CBD Life Sciences Inc.'s annual revenue. Analystsexpect the market for mushroom-infused supplements to reach $18 billion by 2028, and with the unique blend of ingredients in this product, CBD Life Sciences Inc. is poised to capture a substantial portion of that market. This launch is expected to drive a revenue increase of 20% within the first year, positioning the company at the forefront of the wellness supplement industry.お知らせ • Sep 05CBD Life Sciences Inc. Unveils Mellow MorningsCBD Life Sciences Inc. announced the launch of its latest innovation, Mellow Mornings, a nano CBD Coffee Creamer poised to disrupt the burgeoning CBD coffee market. Available in Pumpkin Spice Cheesecake, Pumpkin, Vanilla and Classic flavors, each bottle of Mellow Mornings contains 1000mg of CBD, offering a powerful, flavorful, and health-boosting addition to daily coffee routine. Riding the Wave of a Growing Market: The CBD coffee market is experiencing rapid growth nationwide, with consumers increasingly seeking out wellness-oriented products that seamlessly integrate into their daily lives. Industry reports project the CBD-infused beverage market to reach $2.6 billion by 2025, driven by the rising popularity of functional beverages. Mellow Mornings is strategically positioned to capitalize on this trend, offering a unique product that combines the comforting ritual of coffee with the therapeutic benefits of CBD. Significant Revenue Potential: Mellow Mornings represents a substantial revenue opportunity for CBD Life Sciences Inc. With the nationwide growth of CBD coffee, the company projects that this new product could add up to $2 million in annual revenue within its first year of launch. This estimate is based on anticipated sales from both direct-to-consumer channels and partnerships with coffee shops and retailers across the country. Revolutionary CBD Delivery for Maximum Efficacy: Leveraging cutting-edge nanotechnology, Mellow Mornings offers superior bioavailability, ensuring that the CBD is absorbed more efficiently by the body. This means that consumers can experience the calming and wellness benefits of CBD more effectively than with traditional formulations. Each bottle of Mellow Mornings is up to 10 times more effective, making it a standout product in a crowded market. Adoption by Local Coffee Shops: Mellow Mornings has already garnered attention from local coffee shops, where it is being used to create specialty CBD Lattes and other beverages. This early adoption is a testament to the product's quality and potential to become a staple in the CBD coffee market.お知らせ • Jul 10CBD Life Sciences Inc. Through Its Wholly Owned Subsidiary, The CBD Vault Inc. Launches New Line of Kava & Kratom ShotsCBD Life Sciences Inc. through its wholly owned subsidiary, The CBD Vault Inc. announced the launch of its new line of Kava & Kratom shots. Designed to provide a natural boost of energy and relaxation, these shots are the latest addition to the company's innovative product lineup. Product Highlights: Natural Ingredients: Kava & Kratom shots are crafted using the highest quality natural ingredients, ensuring a safe and effective experience. Convenient & Portable: Packaged in a sleek, portable bottle, these shots are perfect for on-the-go use, making it easy to enjoy their benefits anytime, anywhere. Balanced Formulation: The carefully balanced blend of Kava and Kratom provides a harmonious mix of relaxation and energy, helping stay focused and calm throughout the day. Great Taste: Available in a delicious apple flavor, shots are as enjoyable to drink as they are effective. Kava and Kratom are two powerful botanicals known for their unique properties. Kava, traditionally used in Pacific Island cultures, is renowned for its calming effects, while Kratom, native to Southeast Asia, is celebrated for its stimulating and pain-relieving properties. Together, they offer a synergistic effect that supports both mental and physical well-being.お知らせ • May 03CBD Life Sciences Inc. has filed a Follow-on Equity Offering.CBD Life Sciences Inc. has filed a Follow-on Equity Offering. Security Name: Common Stock Security Type: Common Stock Securities Offered: 3,000,000,000お知らせ • Jan 12CBD Life Sciences Inc. Launches Premium Terpene Infused OilCBD Life Sciences through its wholly owned subsidiary, LBC Bioscience Inc. announced that the company developed new CBD Oil infused with top-of-the-line terpenes and will be available to purchase in the next couple of days on LBC Bioscience Inc.'s website. LBC Bioscience Inc. has recently established a manufacturing facility for product development along with other operations, and the company has formulated a Premium Non-GMO tincture coming in strengths of 500MG, 1500MG, & 3000MG! This tincture will come in 14 different flavors and will be packed with some of the best terpenes on the market today. LBC Bioscience's all-new powerhouse product boasts rapid absorption, four times the potency of other hemp-derived tinctures and stronger than any products the company currently carries. Its high-quality ingredient combination has shown impressive results with satisfaction following the sampling process. LBC's new tincture is focused on assisting muscle discomfort, stress, and sleep deprivation. All products made by LBC Bioscience are carefully blended to ensure maximum consistency along with top-tier Third Party Lab Testing for verification. In 2023, LBC Bioscience Inc. will continue to strive to improve its customers' daily lives with high-quality premium products that are not only easily accessible, but affordable.株主還元CBDLUS PharmaceuticalsUS 市場7D-25.0%4.9%1.0%1Y0%44.2%28.7%株主還元を見る業界別リターン: CBDL過去 1 年間で44.2 % の収益を上げたUS Pharmaceuticals業界を下回りました。リターン対市場: CBDLは、過去 1 年間で28.7 % のリターンを上げたUS市場を下回りました。価格変動Is CBDL's price volatile compared to industry and market?CBDL volatilityCBDL Average Weekly Movement82.9%Pharmaceuticals Industry Average Movement10.1%Market Average Movement7.2%10% most volatile stocks in US Market16.4%10% least volatile stocks in US Market3.1%安定した株価: CBDLの株価は、 US市場と比較して過去 3 か月間で変動しています。時間の経過による変動: CBDLの 週次ボラティリティ は、過去 1 年間で69%から83%に増加しました。会社概要設立従業員CEO（最高経営責任者ウェブサイトn/an/aLisa Nelsonwww.thecbdvault.comCBDライフサイエンス社は、カンナビジオールベースのオーガニック製品の開発・販売を行っている。同社のカンナビジオールベースのオーガニック製品には、ヘンプドロップ、マッサージオイル、回復鎮痛クリーム、不安・睡眠ソリューションサプリメント、エディブル、コーヒー、ワイン、スキンケアライン、タブレット、ペット用製品ラインなどがある。本社はアリゾナ州スコッツデール。もっと見るCBD Life Sciences Inc. 基礎のまとめCBD Life Sciences の収益と売上を時価総額と比較するとどうか。CBDL 基礎統計学時価総額US$1.71m収益（TTM）-US$107.44k売上高(TTM)US$178.45k0.0xP/Sレシオ0.0xPER（株価収益率CBDL は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計CBDL 損益計算書（TTM）収益US$178.45k売上原価US$98.04k売上総利益US$80.41kその他の費用US$187.84k収益-US$107.44k直近の収益報告Mar 31, 2024次回決算日該当なし一株当たり利益（EPS）0グロス・マージン0.00%純利益率0.00%有利子負債／自己資本比率0.0%CBDL の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 04:04終値2026/05/22 00:00収益2024/03/31年間収益2023/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋CBD Life Sciences Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • May 16CBD Life Sciences Inc. has filed a Follow-on Equity Offering in the amount of $0.448 million.CBD Life Sciences Inc. has filed a Follow-on Equity Offering in the amount of $0.448 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 4,000,000,000 Price\Range: $0.000112 Discount Per Security: $0
お知らせ • Jan 07CBD Life Sciences, Inc. Secures Breakthrough Walmart Marketplace Approval for Mushroom Supplement, Setting the Stage for Unprecedented GrowthCBD Life Sciences Inc. announce that its Mushroom Madness Rise Gummies, featuring a powerful Lion's Mane mushroom blend, have officially been approved for sale and are now available on Walmart Marketplace. This monumental approval opens the door for CBDL to tap into Walmart's expansive e-commerce ecosystem, providing a pathway to substantial revenue growth while strengthening its position in the rapidly expanding functional mushroom market. The global functional mushroom market continues to surge, projected to reach $42.4 billion by 2028, with Lion's Mane products leading the charge due to their cognitive health benefits. CBDL's Mushroom Madness Rise Gummies, formulated for focus, clarity, and enhanced mental performance, are well-positioned to meet the increasing demand for natural wellness solutions. Walmart Marketplace, recognized as one of the fastest-growing online retail platforms, boasts over 100 million monthly visitors. With third-party sellers generating substantial portions of Walmart's e-commerce revenue, the platform offers unmatched scalability and visibility for emerging brands. CBDL's entry onto Walmart Marketplace provides logistical efficiencies, enhanced consumer trust, and a direct line to an enormous, ever-expanding customer base. Industry reports indicate that third-party sellers often experience double-digit sales growth within months of launching on Walmart Marketplace. This offers CBDL an unprecedented opportunity to scale its revenues rapidly, further bolstered by Walmart's robust digital marketing support and fulfillment network. CBD Life Sciences has already achieved impressive financial growth, recording a 1405.46% increase in revenue since February 2024. The company expects Walmart Marketplace to significantly enhance its revenue stream, given the rapid consumer adoption of functional mushroom products and CBD-infused supplements. The Mushroom Madness Rise Gummies are a strategic addition to CBDL's product lineup, aligning with the company's commitment to offering scientifically formulated, high-efficacy wellness products. These gummies not only serve a growing wellness market but also position CBDL to capture a significant share of the $20 billion U.S. supplement industry. As part of its long-term strategy, CBDL plans to launch additional top-selling products on Walmart Marketplace, including its highly anticipated nano-CBD supplements and mushroom-enhanced nutritional powders.
お知らせ • Dec 03CBD Life Sciences Inc. Announces New Delta-8 100MG Gummies Designed to Support Individuals Living with Alzheimer'sCBD Life Sciences Inc. announced the launch of its groundbreaking Delta-8 100mg Gummies, specially formulated to support individuals living with Alzheimer's disease. These expertly crafted gummies offer gentle relief and enhanced well-being, addressing the unique needs of patients and their families navigating the challenges of neurodegenerative conditions. CBD Life Sciences' entry into this specialized segment of the $6 billion U.S. edibles market positions the company as a pioneer in creating products tailored to an underserved demographic. As the population ages and awareness of natural alternatives grows, Delta-8 products are rapidly gaining traction as effective solutions for managing symptoms associated with Alzheimer's and related conditions. A Product Born from Real Needs and Scientific Innovation: The development of these gummies is deeply rooted in the stories of CBD Life Sciences' clients, who shared how Delta-8 products have positively impacted their loved ones living with Alzheimer's. This heartfelt feedback spurred the creation of a product aimed at addressing symptoms such as anxiety, restlessness, agitation, and mood swings, all while promoting cognitive calmness and overall quality of life.Delta-8, a naturally occurring cannabinoid, is celebrated for its mild yet effective benefits. Unlike more aggressive treatments, Delta-8 provides a balance of support without overwhelming psychoactive effects, making it an ideal choice for seniors seeking natural relief. Revenue and Growth Potential: The Alzheimer's population in the United States is expected to exceed 12.7 million by 2050, creating a significant and growing demand for targeted wellness products. Early projections indicate that this product line could contribute an additional $3 million in revenue within its first year, as CBD Life Sciences continues to meet the rising interest in cannabinoid-based solutions for elderly care. The senior segment of the edibles market is rapidly emerging as a key growth area. A recent study reported a 300% increase in cannabinoid use among individuals aged 65 and older over the past decade. This demographic is increasingly turning to natural products like Delta-8 for their ability to support physical and cognitive health without the side effects often associated with pharmaceuticals. Meeting the Needs of an Underserved Market: CBD Life Sciences'Delta-8 Gummies are designed with seniors in mind. These gummies are made from all-natural ingredients, offering easy consumption, precise dosing, and a discreet form factor. Rigorous third-party testing ensures their purity, potency, and consistency, providing families and caregivers with confidence in their safety and efficacy. The gummies' formulation emphasizes cognitive support and emotional balance, helping to manage the everyday challenges of Alzheimer's while offering peace of mind to those providing care. CBD Life Sciences: Setting the Standard in Innovation: The launch of the Delta-8 Gummies for Alzheimer's marks another milestone in CBD Life Sciences' remarkable growth trajectory. Since February 2024, the company has achieved a 1405.46% increase in revenue, driven by its commitment to delivering high-quality, innovative products that resonate with consumers. This latest product also highlights the company's strategic focus on expanding its reach in the health and wellness sector, where demand for cannabinoid-based solutions continues to skyrocket. By addressing the specific needs of aging individuals and their families, CBD Life Sciences solidifies its position as a trusted leader in the industry.
お知らせ • Nov 02CBD Life Sciences Inc. Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into A Booming $20 Billion MarketCBD Life Sciences Inc. sets a new industry standard with its launch of a high-performance line of mushroom-infused gummies, designed to meet the surging demand for wellness products in a projected $20 billion market. Focused on energy, sleep, and sexual wellness, these unique formulations offer CBDL shareholders and new investors an unprecedented growth opportunity in an exploration sector. With an expanding consumer focus on holistic health and functional ingredients, CBDL's Rise, Dream, and Bloom Gummies each bring targeted benefits, including cognitive enhancement, restful sleep, and boosted vitality. These products are strategically positioned to address top wellness priorities, blending potent natural ingredients with advanced formulation technology. This launch is expected to significantly contribute to CBDL's revenue stream, enhancing shareholder value and setting the company apart as an innovator in functional wellness. Rise Gummies are formulated to support focus and energy, each containing 500mg of Lion's Mane Mushroom, 1 microgram of B12, and 25mg of Ginseng. This combination aligns with a growing segment of consumers seeking natural solutions to boost mental clarity and productivity. Dream Gummies provide natural support for relaxation and sleep, with 500mg of Reishi Mushroom, 25mg of Kava, and 10mg of 5-HTP. With sleep wellness now a top priority for many, Dream Gummies offer a non-habit-forming solution to support stress relief and emotional balance. Bloom Gummies offer a targeted formula for sexual wellness and vitality, incorporating 500mg of Cordyceps Mushroom along with Tongkat Ali, Ginkgo Biloba, Ginseng, L-Arginine, Ashwagandha, and Maca. With its pioneering approach to wellness, CBDL is dedicated to securing sustained value for investors by remaining at the forefront of natural health innovation.
お知らせ • Oct 03CBD Life Sciences, Inc. Launches CBD Horse PasteCBD Life Sciences Inc. announced the launch of its latest product, the CBD Horse Paste. This veterinarian-designed formulation is the first of its kind, offering unparalleled support for horses facing both physical and psychological challenges. Equine health concerns such as muscle stiffness, joint pain, and anxiety can significantly affect a horse's well-being. The CBD Horse Paste addresses these issues with a unique combination of cannabinoids and terpenes, providing an easy-to-administer solution that stays in the horse's mouth longer than CBD oils, ensuring maximum absorption. Each syringe delivers 500mg of premium CBD with a flavor horses love, making it ideal for stress-inducing situations like farrier visits or long trailer rides. Key Benefits of CBD Horse Paste: Veterinarian-Designed Formulation: Created by equine health experts for maximum effectiveness. Comprehensive Health Support: Eases muscle stiffness, joint issues, and stress-related behaviors like boredom and anxiety. Easy-to-Use: Each syringe contains four doses, making it convenient for horse owners. Delicious Flavor: The paste's flavor ensures horses readily accept it. Versatile Application: Perfect for use during stressful situations, such as travel, farrier visits, and training sessions. Innovative CBD for Equine Wellness: The CBD Horse Paste not only addresses common equine health concerns but also serves as a natural alternative to traditional calming agents and medications. By leveraging the powerful properties of CBD and terpenes, horses can experience relief from arthritis-induced stiffness and joint pain, as well as a reduction in anxiety caused by environmental changes, isolation, or past trauma.
お知らせ • Sep 24CBD Life Sciences, Inc. Announces Expanding Revenue Stream with Walmart MarketplaceCBD Life Sciences Inc. announced the launch of its product line on Walmart Marketplace. This milestone marks a significant leap in retail strategy, poised to drive substantial revenue growth and expand market reach to millions of potential customers. Market Expansion: By entering the Walmart Marketplace, the company are now accessible to one of the largest retail platforms in the world, boasting over 120 million monthly visitors. This launch strategically positions CBDL to significantly increase brand visibility and consumer base. Revenue Growth: Early forecasts project a substantial revenue boost, with a projected increase of 35% in annual sales due to this new distribution channel. The company revenue growth over the past 12 months has already seen a 20% rise, and the company expects accelerated growth driven by this expansion. Product Line on Walmart: The initial offerings will include top-selling Nano CBD Coffee Creamer, Mellow Mornings, and CBD Pain Cream, which have seen growing demand in local markets. These products, praised for their effectiveness, will now have national distribution, broadening customer base across the U.S. Investor Impact: This move opens additional streams of revenue that will enhance shareholder value. By diversifying sales channels, the company aim to increase its gross margins by 10% while driving stronger returns for investors over the next fiscal year. A Proven Path to Growth: As a small but rapidly growing company, the company recognize that entering high-traffic marketplaces like Walmart is a powerful catalyst for scaling. The company continue to prioritize innovation in product lines and have seen positive feedback from both consumers and local retailers. With products now on Walmart Marketplace, the company anticipates a robust competitive edge and a much larger footprint in the booming CBD sector, which is projected to reach $47.22 billion by 2028.
お知らせ • May 16CBD Life Sciences Inc. has filed a Follow-on Equity Offering in the amount of $0.448 million.CBD Life Sciences Inc. has filed a Follow-on Equity Offering in the amount of $0.448 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 4,000,000,000 Price\Range: $0.000112 Discount Per Security: $0
お知らせ • Jan 07CBD Life Sciences, Inc. Secures Breakthrough Walmart Marketplace Approval for Mushroom Supplement, Setting the Stage for Unprecedented GrowthCBD Life Sciences Inc. announce that its Mushroom Madness Rise Gummies, featuring a powerful Lion's Mane mushroom blend, have officially been approved for sale and are now available on Walmart Marketplace. This monumental approval opens the door for CBDL to tap into Walmart's expansive e-commerce ecosystem, providing a pathway to substantial revenue growth while strengthening its position in the rapidly expanding functional mushroom market. The global functional mushroom market continues to surge, projected to reach $42.4 billion by 2028, with Lion's Mane products leading the charge due to their cognitive health benefits. CBDL's Mushroom Madness Rise Gummies, formulated for focus, clarity, and enhanced mental performance, are well-positioned to meet the increasing demand for natural wellness solutions. Walmart Marketplace, recognized as one of the fastest-growing online retail platforms, boasts over 100 million monthly visitors. With third-party sellers generating substantial portions of Walmart's e-commerce revenue, the platform offers unmatched scalability and visibility for emerging brands. CBDL's entry onto Walmart Marketplace provides logistical efficiencies, enhanced consumer trust, and a direct line to an enormous, ever-expanding customer base. Industry reports indicate that third-party sellers often experience double-digit sales growth within months of launching on Walmart Marketplace. This offers CBDL an unprecedented opportunity to scale its revenues rapidly, further bolstered by Walmart's robust digital marketing support and fulfillment network. CBD Life Sciences has already achieved impressive financial growth, recording a 1405.46% increase in revenue since February 2024. The company expects Walmart Marketplace to significantly enhance its revenue stream, given the rapid consumer adoption of functional mushroom products and CBD-infused supplements. The Mushroom Madness Rise Gummies are a strategic addition to CBDL's product lineup, aligning with the company's commitment to offering scientifically formulated, high-efficacy wellness products. These gummies not only serve a growing wellness market but also position CBDL to capture a significant share of the $20 billion U.S. supplement industry. As part of its long-term strategy, CBDL plans to launch additional top-selling products on Walmart Marketplace, including its highly anticipated nano-CBD supplements and mushroom-enhanced nutritional powders.
お知らせ • Dec 03CBD Life Sciences Inc. Announces New Delta-8 100MG Gummies Designed to Support Individuals Living with Alzheimer'sCBD Life Sciences Inc. announced the launch of its groundbreaking Delta-8 100mg Gummies, specially formulated to support individuals living with Alzheimer's disease. These expertly crafted gummies offer gentle relief and enhanced well-being, addressing the unique needs of patients and their families navigating the challenges of neurodegenerative conditions. CBD Life Sciences' entry into this specialized segment of the $6 billion U.S. edibles market positions the company as a pioneer in creating products tailored to an underserved demographic. As the population ages and awareness of natural alternatives grows, Delta-8 products are rapidly gaining traction as effective solutions for managing symptoms associated with Alzheimer's and related conditions. A Product Born from Real Needs and Scientific Innovation: The development of these gummies is deeply rooted in the stories of CBD Life Sciences' clients, who shared how Delta-8 products have positively impacted their loved ones living with Alzheimer's. This heartfelt feedback spurred the creation of a product aimed at addressing symptoms such as anxiety, restlessness, agitation, and mood swings, all while promoting cognitive calmness and overall quality of life.Delta-8, a naturally occurring cannabinoid, is celebrated for its mild yet effective benefits. Unlike more aggressive treatments, Delta-8 provides a balance of support without overwhelming psychoactive effects, making it an ideal choice for seniors seeking natural relief. Revenue and Growth Potential: The Alzheimer's population in the United States is expected to exceed 12.7 million by 2050, creating a significant and growing demand for targeted wellness products. Early projections indicate that this product line could contribute an additional $3 million in revenue within its first year, as CBD Life Sciences continues to meet the rising interest in cannabinoid-based solutions for elderly care. The senior segment of the edibles market is rapidly emerging as a key growth area. A recent study reported a 300% increase in cannabinoid use among individuals aged 65 and older over the past decade. This demographic is increasingly turning to natural products like Delta-8 for their ability to support physical and cognitive health without the side effects often associated with pharmaceuticals. Meeting the Needs of an Underserved Market: CBD Life Sciences'Delta-8 Gummies are designed with seniors in mind. These gummies are made from all-natural ingredients, offering easy consumption, precise dosing, and a discreet form factor. Rigorous third-party testing ensures their purity, potency, and consistency, providing families and caregivers with confidence in their safety and efficacy. The gummies' formulation emphasizes cognitive support and emotional balance, helping to manage the everyday challenges of Alzheimer's while offering peace of mind to those providing care. CBD Life Sciences: Setting the Standard in Innovation: The launch of the Delta-8 Gummies for Alzheimer's marks another milestone in CBD Life Sciences' remarkable growth trajectory. Since February 2024, the company has achieved a 1405.46% increase in revenue, driven by its commitment to delivering high-quality, innovative products that resonate with consumers. This latest product also highlights the company's strategic focus on expanding its reach in the health and wellness sector, where demand for cannabinoid-based solutions continues to skyrocket. By addressing the specific needs of aging individuals and their families, CBD Life Sciences solidifies its position as a trusted leader in the industry.
お知らせ • Nov 02CBD Life Sciences Inc. Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into A Booming $20 Billion MarketCBD Life Sciences Inc. sets a new industry standard with its launch of a high-performance line of mushroom-infused gummies, designed to meet the surging demand for wellness products in a projected $20 billion market. Focused on energy, sleep, and sexual wellness, these unique formulations offer CBDL shareholders and new investors an unprecedented growth opportunity in an exploration sector. With an expanding consumer focus on holistic health and functional ingredients, CBDL's Rise, Dream, and Bloom Gummies each bring targeted benefits, including cognitive enhancement, restful sleep, and boosted vitality. These products are strategically positioned to address top wellness priorities, blending potent natural ingredients with advanced formulation technology. This launch is expected to significantly contribute to CBDL's revenue stream, enhancing shareholder value and setting the company apart as an innovator in functional wellness. Rise Gummies are formulated to support focus and energy, each containing 500mg of Lion's Mane Mushroom, 1 microgram of B12, and 25mg of Ginseng. This combination aligns with a growing segment of consumers seeking natural solutions to boost mental clarity and productivity. Dream Gummies provide natural support for relaxation and sleep, with 500mg of Reishi Mushroom, 25mg of Kava, and 10mg of 5-HTP. With sleep wellness now a top priority for many, Dream Gummies offer a non-habit-forming solution to support stress relief and emotional balance. Bloom Gummies offer a targeted formula for sexual wellness and vitality, incorporating 500mg of Cordyceps Mushroom along with Tongkat Ali, Ginkgo Biloba, Ginseng, L-Arginine, Ashwagandha, and Maca. With its pioneering approach to wellness, CBDL is dedicated to securing sustained value for investors by remaining at the forefront of natural health innovation.
お知らせ • Oct 03CBD Life Sciences, Inc. Launches CBD Horse PasteCBD Life Sciences Inc. announced the launch of its latest product, the CBD Horse Paste. This veterinarian-designed formulation is the first of its kind, offering unparalleled support for horses facing both physical and psychological challenges. Equine health concerns such as muscle stiffness, joint pain, and anxiety can significantly affect a horse's well-being. The CBD Horse Paste addresses these issues with a unique combination of cannabinoids and terpenes, providing an easy-to-administer solution that stays in the horse's mouth longer than CBD oils, ensuring maximum absorption. Each syringe delivers 500mg of premium CBD with a flavor horses love, making it ideal for stress-inducing situations like farrier visits or long trailer rides. Key Benefits of CBD Horse Paste: Veterinarian-Designed Formulation: Created by equine health experts for maximum effectiveness. Comprehensive Health Support: Eases muscle stiffness, joint issues, and stress-related behaviors like boredom and anxiety. Easy-to-Use: Each syringe contains four doses, making it convenient for horse owners. Delicious Flavor: The paste's flavor ensures horses readily accept it. Versatile Application: Perfect for use during stressful situations, such as travel, farrier visits, and training sessions. Innovative CBD for Equine Wellness: The CBD Horse Paste not only addresses common equine health concerns but also serves as a natural alternative to traditional calming agents and medications. By leveraging the powerful properties of CBD and terpenes, horses can experience relief from arthritis-induced stiffness and joint pain, as well as a reduction in anxiety caused by environmental changes, isolation, or past trauma.
お知らせ • Sep 24CBD Life Sciences, Inc. Announces Expanding Revenue Stream with Walmart MarketplaceCBD Life Sciences Inc. announced the launch of its product line on Walmart Marketplace. This milestone marks a significant leap in retail strategy, poised to drive substantial revenue growth and expand market reach to millions of potential customers. Market Expansion: By entering the Walmart Marketplace, the company are now accessible to one of the largest retail platforms in the world, boasting over 120 million monthly visitors. This launch strategically positions CBDL to significantly increase brand visibility and consumer base. Revenue Growth: Early forecasts project a substantial revenue boost, with a projected increase of 35% in annual sales due to this new distribution channel. The company revenue growth over the past 12 months has already seen a 20% rise, and the company expects accelerated growth driven by this expansion. Product Line on Walmart: The initial offerings will include top-selling Nano CBD Coffee Creamer, Mellow Mornings, and CBD Pain Cream, which have seen growing demand in local markets. These products, praised for their effectiveness, will now have national distribution, broadening customer base across the U.S. Investor Impact: This move opens additional streams of revenue that will enhance shareholder value. By diversifying sales channels, the company aim to increase its gross margins by 10% while driving stronger returns for investors over the next fiscal year. A Proven Path to Growth: As a small but rapidly growing company, the company recognize that entering high-traffic marketplaces like Walmart is a powerful catalyst for scaling. The company continue to prioritize innovation in product lines and have seen positive feedback from both consumers and local retailers. With products now on Walmart Marketplace, the company anticipates a robust competitive edge and a much larger footprint in the booming CBD sector, which is projected to reach $47.22 billion by 2028.
お知らせ • Sep 18CBD Life Sciences, Inc. Unveils Groundbreaking Nutritional Supplement Infused with Mushroom Extracts, Set to Drive Revenue and Revolutionize WellnessCBD Life Sciences Inc. launched a cutting-edge nutritional supplement powder designed to harness the powerful health benefits of natural ingredients. This new supplement contains a proprietary blend of reishi mushroom extract, lion's mane mushroom extract, and ashwagandha root extract, offering an integrated approach to wellness by reducing stress, supporting brain health, and enhancing the immune system. Recent studies highlight the effectiveness of reishi extract, not only in boosting the immune system but also in slowing or stopping tumor growth, a feature that positions this product as an essential addition to the wellness market. The blend of lion's mane extract and ashwagandha root provides additional cognitive support and anti-inflammatory benefits, making it an all-around solution for physical and mental well-being. Unrivaled Benefits of Key Ingredients: Reishi Mushroom Extract: Renowned for its immune-boosting and anti-cancer properties, research suggests it can slow tumor growth, making it one of the most potent natural supplements available today. Lion's Mane Mushroom Extract: Known for supporting brain health, lion's mane helps to enhance cognitive function and promote nerve regeneration, ideal for those seeking long-term mental clarity. Ashwagandha Root Extract: Widely celebrated for reducing stress and its anti-inflammatory effects, ashwagandha contributes to overall mental health and physical recovery. Revenue Projections & Market Potential.With the global supplement market experiencing rapid growth, the introduction of this new product is projected to significantly boost CBD Life Sciences Inc.'s annual revenue. Analystsexpect the market for mushroom-infused supplements to reach $18 billion by 2028, and with the unique blend of ingredients in this product, CBD Life Sciences Inc. is poised to capture a substantial portion of that market. This launch is expected to drive a revenue increase of 20% within the first year, positioning the company at the forefront of the wellness supplement industry.
お知らせ • Sep 05CBD Life Sciences Inc. Unveils Mellow MorningsCBD Life Sciences Inc. announced the launch of its latest innovation, Mellow Mornings, a nano CBD Coffee Creamer poised to disrupt the burgeoning CBD coffee market. Available in Pumpkin Spice Cheesecake, Pumpkin, Vanilla and Classic flavors, each bottle of Mellow Mornings contains 1000mg of CBD, offering a powerful, flavorful, and health-boosting addition to daily coffee routine. Riding the Wave of a Growing Market: The CBD coffee market is experiencing rapid growth nationwide, with consumers increasingly seeking out wellness-oriented products that seamlessly integrate into their daily lives. Industry reports project the CBD-infused beverage market to reach $2.6 billion by 2025, driven by the rising popularity of functional beverages. Mellow Mornings is strategically positioned to capitalize on this trend, offering a unique product that combines the comforting ritual of coffee with the therapeutic benefits of CBD. Significant Revenue Potential: Mellow Mornings represents a substantial revenue opportunity for CBD Life Sciences Inc. With the nationwide growth of CBD coffee, the company projects that this new product could add up to $2 million in annual revenue within its first year of launch. This estimate is based on anticipated sales from both direct-to-consumer channels and partnerships with coffee shops and retailers across the country. Revolutionary CBD Delivery for Maximum Efficacy: Leveraging cutting-edge nanotechnology, Mellow Mornings offers superior bioavailability, ensuring that the CBD is absorbed more efficiently by the body. This means that consumers can experience the calming and wellness benefits of CBD more effectively than with traditional formulations. Each bottle of Mellow Mornings is up to 10 times more effective, making it a standout product in a crowded market. Adoption by Local Coffee Shops: Mellow Mornings has already garnered attention from local coffee shops, where it is being used to create specialty CBD Lattes and other beverages. This early adoption is a testament to the product's quality and potential to become a staple in the CBD coffee market.
お知らせ • Jul 10CBD Life Sciences Inc. Through Its Wholly Owned Subsidiary, The CBD Vault Inc. Launches New Line of Kava & Kratom ShotsCBD Life Sciences Inc. through its wholly owned subsidiary, The CBD Vault Inc. announced the launch of its new line of Kava & Kratom shots. Designed to provide a natural boost of energy and relaxation, these shots are the latest addition to the company's innovative product lineup. Product Highlights: Natural Ingredients: Kava & Kratom shots are crafted using the highest quality natural ingredients, ensuring a safe and effective experience. Convenient & Portable: Packaged in a sleek, portable bottle, these shots are perfect for on-the-go use, making it easy to enjoy their benefits anytime, anywhere. Balanced Formulation: The carefully balanced blend of Kava and Kratom provides a harmonious mix of relaxation and energy, helping stay focused and calm throughout the day. Great Taste: Available in a delicious apple flavor, shots are as enjoyable to drink as they are effective. Kava and Kratom are two powerful botanicals known for their unique properties. Kava, traditionally used in Pacific Island cultures, is renowned for its calming effects, while Kratom, native to Southeast Asia, is celebrated for its stimulating and pain-relieving properties. Together, they offer a synergistic effect that supports both mental and physical well-being.
お知らせ • May 03CBD Life Sciences Inc. has filed a Follow-on Equity Offering.CBD Life Sciences Inc. has filed a Follow-on Equity Offering. Security Name: Common Stock Security Type: Common Stock Securities Offered: 3,000,000,000
お知らせ • Jan 12CBD Life Sciences Inc. Launches Premium Terpene Infused OilCBD Life Sciences through its wholly owned subsidiary, LBC Bioscience Inc. announced that the company developed new CBD Oil infused with top-of-the-line terpenes and will be available to purchase in the next couple of days on LBC Bioscience Inc.'s website. LBC Bioscience Inc. has recently established a manufacturing facility for product development along with other operations, and the company has formulated a Premium Non-GMO tincture coming in strengths of 500MG, 1500MG, & 3000MG! This tincture will come in 14 different flavors and will be packed with some of the best terpenes on the market today. LBC Bioscience's all-new powerhouse product boasts rapid absorption, four times the potency of other hemp-derived tinctures and stronger than any products the company currently carries. Its high-quality ingredient combination has shown impressive results with satisfaction following the sampling process. LBC's new tincture is focused on assisting muscle discomfort, stress, and sleep deprivation. All products made by LBC Bioscience are carefully blended to ensure maximum consistency along with top-tier Third Party Lab Testing for verification. In 2023, LBC Bioscience Inc. will continue to strive to improve its customers' daily lives with high-quality premium products that are not only easily accessible, but affordable.
